{"id":1081,"date":"2013-10-31T20:29:50","date_gmt":"2013-10-31T20:29:50","guid":{"rendered":"https:\/\/www.chambleeryan.com\/?p=1081"},"modified":"2013-10-31T20:29:50","modified_gmt":"2013-10-31T20:29:50","slug":"attorney-david-m-walsh-discusses-legal-strategy-granuflonaturlyte-lawsuit-fox4-%e2%97%a6-health-care","status":"publish","type":"post","link":"https:\/\/www.chambleeryan.com\/attorney-david-m-walsh-discusses-legal-strategy-granuflonaturlyte-lawsuit-fox4-%e2%97%a6-health-care\/","title":{"rendered":"David Walsh Discusses Legal Strategy in GranuFlo\/NaturLyte Lawsuit on FOX4 \u25e6 Health Care"},"content":{"rendered":"<p>In this FOX4 News interview, Dallas health care attorney David M. Walsh, IV discusses legal strategies that the producer of GranuFlo and NaturaLyte might use in defending itself against charges that its drug caused the death of patients. &#8220;The FDA approval (of the drug) would be one defense,&#8221; says Mr. Walsh, a partner at Dallas-based Chamblee, Ryan, Kershaw &amp; Anderson, P.C. &#8220;A second defense would be looking at plaintiffs&#8217; individual conditions, saying the drug didn&#8217;t cause it, because these are dialysis patients, and they were very sick to begin with. The third way would be to attribute fault to the doctors or health care providers, because the FDA recall mentions that it was given at inappropriate doses.&#8221; Mr. Walsh is not involved in the GranuFlo\/NaturaLyte litigation.<\/p>\n<p>The news piece can be found <a href=\"http:\/\/www.youtube.com\/watch?v=xMzOLDHAGvs\" target=\"_blank\" rel=\"noopener\">here<\/a>.<\/p>\n<p>Attorney: <a title=\"David M. Walsh, IV\" href=\"https:\/\/www.chambleeryan.com\/attorney-bios\/david-m-walsh-iv\/\">David M. Walsh, IV<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>In this FOX4 News interview, Dallas health care attorney David M. Walsh, IV discusses legal strategies that the producer of GranuFlo and NaturaLyte might use in defending itself against charges that its drug caused the death of patients. &#8220;The FDA approval (of the drug) would be one defense,&#8221; says Mr. Walsh, a partner at Dallas-based [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[7],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>David Walsh Discusses Legal Strategy in GranuFlo\/NaturLyte Lawsuit on FOX4 \u25e6 Health Care - Chamblee Ryan<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.chambleeryan.com\/attorney-david-m-walsh-discusses-legal-strategy-granuflonaturlyte-lawsuit-fox4-\u25e6-health-care\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"David Walsh Discusses Legal Strategy in GranuFlo\/NaturLyte Lawsuit on FOX4 \u25e6 Health Care - Chamblee Ryan\" \/>\n<meta property=\"og:description\" content=\"In this FOX4 News interview, Dallas health care attorney David M. Walsh, IV discusses legal strategies that the producer of GranuFlo and NaturaLyte might use in defending itself against charges that its drug caused the death of patients. &#8220;The FDA approval (of the drug) would be one defense,&#8221; says Mr. Walsh, a partner at Dallas-based [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.chambleeryan.com\/attorney-david-m-walsh-discusses-legal-strategy-granuflonaturlyte-lawsuit-fox4-\u25e6-health-care\/\" \/>\n<meta property=\"og:site_name\" content=\"Chamblee Ryan\" \/>\n<meta property=\"article:published_time\" content=\"2013-10-31T20:29:50+00:00\" \/>\n<meta name=\"author\" content=\"JoAnn Ross\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"JoAnn Ross\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.chambleeryan.com\/attorney-david-m-walsh-discusses-legal-strategy-granuflonaturlyte-lawsuit-fox4-%e2%97%a6-health-care\/\",\"url\":\"https:\/\/www.chambleeryan.com\/attorney-david-m-walsh-discusses-legal-strategy-granuflonaturlyte-lawsuit-fox4-%e2%97%a6-health-care\/\",\"name\":\"David Walsh Discusses Legal Strategy in GranuFlo\/NaturLyte Lawsuit on FOX4 \u25e6 Health Care - Chamblee Ryan\",\"isPartOf\":{\"@id\":\"https:\/\/www.chambleeryan.com\/#website\"},\"datePublished\":\"2013-10-31T20:29:50+00:00\",\"dateModified\":\"2013-10-31T20:29:50+00:00\",\"author\":{\"@id\":\"https:\/\/www.chambleeryan.com\/#\/schema\/person\/0eb0c238f79b16d5ea95eaf0cd72ca48\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.chambleeryan.com\/attorney-david-m-walsh-discusses-legal-strategy-granuflonaturlyte-lawsuit-fox4-%e2%97%a6-health-care\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.chambleeryan.com\/attorney-david-m-walsh-discusses-legal-strategy-granuflonaturlyte-lawsuit-fox4-%e2%97%a6-health-care\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.chambleeryan.com\/attorney-david-m-walsh-discusses-legal-strategy-granuflonaturlyte-lawsuit-fox4-%e2%97%a6-health-care\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.chambleeryan.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"David Walsh Discusses Legal Strategy in GranuFlo\/NaturLyte Lawsuit on FOX4 \u25e6 Health Care\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.chambleeryan.com\/#website\",\"url\":\"https:\/\/www.chambleeryan.com\/\",\"name\":\"Chamblee Ryan\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.chambleeryan.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.chambleeryan.com\/#\/schema\/person\/0eb0c238f79b16d5ea95eaf0cd72ca48\",\"name\":\"JoAnn Ross\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.chambleeryan.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/acdf923e19d4976c5ede6f04b4887a1d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/acdf923e19d4976c5ede6f04b4887a1d?s=96&d=mm&r=g\",\"caption\":\"JoAnn Ross\"},\"url\":\"https:\/\/www.chambleeryan.com\/author\/chamryan_user\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"David Walsh Discusses Legal Strategy in GranuFlo\/NaturLyte Lawsuit on FOX4 \u25e6 Health Care - Chamblee Ryan","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.chambleeryan.com\/attorney-david-m-walsh-discusses-legal-strategy-granuflonaturlyte-lawsuit-fox4-\u25e6-health-care\/","og_locale":"en_US","og_type":"article","og_title":"David Walsh Discusses Legal Strategy in GranuFlo\/NaturLyte Lawsuit on FOX4 \u25e6 Health Care - Chamblee Ryan","og_description":"In this FOX4 News interview, Dallas health care attorney David M. Walsh, IV discusses legal strategies that the producer of GranuFlo and NaturaLyte might use in defending itself against charges that its drug caused the death of patients. &#8220;The FDA approval (of the drug) would be one defense,&#8221; says Mr. Walsh, a partner at Dallas-based [&hellip;]","og_url":"https:\/\/www.chambleeryan.com\/attorney-david-m-walsh-discusses-legal-strategy-granuflonaturlyte-lawsuit-fox4-\u25e6-health-care\/","og_site_name":"Chamblee Ryan","article_published_time":"2013-10-31T20:29:50+00:00","author":"JoAnn Ross","twitter_card":"summary_large_image","twitter_misc":{"Written by":"JoAnn Ross","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.chambleeryan.com\/attorney-david-m-walsh-discusses-legal-strategy-granuflonaturlyte-lawsuit-fox4-%e2%97%a6-health-care\/","url":"https:\/\/www.chambleeryan.com\/attorney-david-m-walsh-discusses-legal-strategy-granuflonaturlyte-lawsuit-fox4-%e2%97%a6-health-care\/","name":"David Walsh Discusses Legal Strategy in GranuFlo\/NaturLyte Lawsuit on FOX4 \u25e6 Health Care - Chamblee Ryan","isPartOf":{"@id":"https:\/\/www.chambleeryan.com\/#website"},"datePublished":"2013-10-31T20:29:50+00:00","dateModified":"2013-10-31T20:29:50+00:00","author":{"@id":"https:\/\/www.chambleeryan.com\/#\/schema\/person\/0eb0c238f79b16d5ea95eaf0cd72ca48"},"breadcrumb":{"@id":"https:\/\/www.chambleeryan.com\/attorney-david-m-walsh-discusses-legal-strategy-granuflonaturlyte-lawsuit-fox4-%e2%97%a6-health-care\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.chambleeryan.com\/attorney-david-m-walsh-discusses-legal-strategy-granuflonaturlyte-lawsuit-fox4-%e2%97%a6-health-care\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.chambleeryan.com\/attorney-david-m-walsh-discusses-legal-strategy-granuflonaturlyte-lawsuit-fox4-%e2%97%a6-health-care\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.chambleeryan.com\/"},{"@type":"ListItem","position":2,"name":"David Walsh Discusses Legal Strategy in GranuFlo\/NaturLyte Lawsuit on FOX4 \u25e6 Health Care"}]},{"@type":"WebSite","@id":"https:\/\/www.chambleeryan.com\/#website","url":"https:\/\/www.chambleeryan.com\/","name":"Chamblee Ryan","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.chambleeryan.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.chambleeryan.com\/#\/schema\/person\/0eb0c238f79b16d5ea95eaf0cd72ca48","name":"JoAnn Ross","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.chambleeryan.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/acdf923e19d4976c5ede6f04b4887a1d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/acdf923e19d4976c5ede6f04b4887a1d?s=96&d=mm&r=g","caption":"JoAnn Ross"},"url":"https:\/\/www.chambleeryan.com\/author\/chamryan_user\/"}]}},"_links":{"self":[{"href":"https:\/\/www.chambleeryan.com\/wp-json\/wp\/v2\/posts\/1081"}],"collection":[{"href":"https:\/\/www.chambleeryan.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.chambleeryan.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.chambleeryan.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.chambleeryan.com\/wp-json\/wp\/v2\/comments?post=1081"}],"version-history":[{"count":0,"href":"https:\/\/www.chambleeryan.com\/wp-json\/wp\/v2\/posts\/1081\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.chambleeryan.com\/wp-json\/wp\/v2\/media?parent=1081"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.chambleeryan.com\/wp-json\/wp\/v2\/categories?post=1081"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.chambleeryan.com\/wp-json\/wp\/v2\/tags?post=1081"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}